Some clinicians disappointed about lung cancer screening advice

the ONA take:

Cancer screening in healthy people seems to be a simple thing, but that’s not so. Breast cancer screening can be controversial, with varying thoughts on recommendations. Now, lung cancer screening is questioned. Despite getting the nod from the US Preventive Services Task Force (USPSTF) for longtime smokers 55 to 79 years old, lung cancer screening is not fully embraced. A federal advisory committee recommended Medicare should not reimburse for lung cancer screening with CT. The USPSTF’s approval of the screening means insurance companies will be required to cover the screening in 2015 through the Affordable Care Act. The Medicare advisory committee cited potential false positives and radiation exposure as reasons against paying for the tests; however, the matter is not settled. A final decision is expected this fall.

Some clinicians disappointed about lung cancer screening advice
Some clinicians disappointed about lung cancer screening advice
Screening healthy people for cancer seems like a no-brainer. Now add lung cancer to the list. In May, a federal advisory committee recommended Medicare should not reimburse for lung cancer screening with CT scans. That comes despite a 2010 national research finding that low-dose CT scans of heavy smokers could detect tumors earlier than X-rays and reduce the risk of death from lung cancer by 20 percent.
READ FULL ARTICLE From The Wichita Eagle
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs